Clinical Trials Sponsored by Yefeng Cai
Total 2065 results
-
Yefeng CaiUnknownStroke | Transient Ischemic Attack | Cerebral Infarction | Subarachnoid Hemorrhage | Cerebral HemorrhageChina
-
JuFeng, HsiaoLotung Poh-Ai HospitalEnrolling by invitationCoronary Heart Disease | Type2 DiabetesTaiwan
-
Kefang LaiNot yet recruitingRefractory Chronic Cough
-
Cheung Chi WaiCompleted
-
CAI HongbingRecruitingOvarian Cancer | Epithelial Ovarian Cancer | Ovarian Cancer, Epithelial | Hyperthermic Intraperitoneal Chemotherapy(HIPEC) | Homologous Recombination Repair Gene MutationChina
-
Dr. Cuong Tran ChiRecruitingAcute Stroke | Ischemic Stroke, Acute | Vertebro Basilar IschemiaVietnam
-
Xueli CaiRecruitingStroke | Thrombectomy | Tandem OcclusionChina
-
Yipeng LiuActive, not recruiting
-
Yipeng LiuActive, not recruitingDiabetic Nephropathies | Thromboembolism | Glomerulonephritis, Membranous | ThrombelastographyChina
-
Yunfeng HouNot yet recruitingPulmonary Infection
-
Yanfeng HouRecruitingSystemic Lupus Erythematosus | Therapy | TelitaciceptChina
-
Yanfeng HouRecruiting
-
Yanfeng HouRecruitingRheumatoid Arthritis | TherapyChina
-
Yipeng LiuActive, not recruiting
-
Yifeng YuRecruiting
-
Yifeng YuCompletedRecurrent Pterygium | Micro-Conjunctival Autografting Combined With Amniotic Membrane TransplantationChina
-
Yifeng YuCompletedMyopia | Small-incision Lenticule Extraction (SMILE) SurgeryChina
-
SCAI TherapeuticsCompletedDry Eye SyndromesKorea, Republic of
-
CTI BioPharmaCompletedAcute Myelogenous LeukemiaUnited States
-
CTI BioPharmaCompletedDiffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 LymphomaUnited States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
-
CTI BioPharmaTerminatedNSCLCUnited States, Canada, Bulgaria, Romania, Russian Federation, Ukraine, Mexico, Argentina, Hungary, Poland, United Kingdom
-
CTI BioPharmaTerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
CTI BioPharmaTerminated
-
CTI BioPharmaTerminatedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Australia, Belgium, Czechia, France, Germany, Hungary, Italy, Netherlands, New Zealand, Russian Federation, United Kingdom
-
CVI PharmaceuticalsUnknown
-
KAI PharmaceuticalsCompletedSecondary HyperparathyroidismUnited States
-
KAI PharmaceuticalsCompleted
-
CTI BioPharmaCompletedDiffuse Large-Cell LymphomaUnited States, Germany, Canada, Italy, France
-
KAI PharmaceuticalsCompletedMyocardial InfarctionUnited States
-
Guo XufengRecruitingEsophageal Squamous Cell Carcinoma | Adjuvant Therapy | Neoadjuvant ChemoimmunotherapyChina
-
Cai KailinUnknownLocally Advanced Gastric CancerChina
-
CTI BioPharmaTerminatedCOVID-19 | COVID | COVID19United States
-
CTI BioPharmaTerminatedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada, France, United Kingdom, Australia, Belgium, Germany, New Zealand, Netherlands, Russian Federation, Hungary, Czechia
-
CTI BioPharmaTerminatedProstate CancerUnited States
-
CTI BioPharmaWithdrawn
-
CTI BioPharmaWithdrawnNon-Hodgkin's LymphomaUnited States
-
CTI BioPharmaTerminated
-
KAI PharmaceuticalsCompletedHyperparathyroidism, SecondaryUnited States, Australia
-
CTI BioPharmaTerminatedLymphoma, Follicular | Lymphoma, Mixed-Cell, Follicular | Lymphoma, Small Cleaved-Cell, Follicular | Lymphoma, Low-GradeUnited States
-
CLI FoundationUnknownST-elevation Myocardial InfarctionItaly
-
CTI BioPharmaCompleted
-
CTI BioPharmaWithdrawnMetastatic CancerUnited States
-
CTI BioPharmaCompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post- Essential Thrombocythemia MyelofibrosisUnited States, Spain, United Kingdom, Hungary, Korea, Republic of, France, Italy, Sweden
-
CTI BioPharmaWithdrawnLymphoma | LeukemiaUnited States
-
CTI BioPharmaTerminated
-
CTI BioPharmaTerminated